doi: 10.1007/s13193-012-0142-6 39 MoZGaoYCaoYGaoFJianL
FLOW The Evaluate Renal Function With Semaglutide Once Weekly (FLOW) trial is the first dedicated kidney outcome study specifically designed to assess the effect of a GLP-1 receptor agonist (once-weekly subcutaneous semaglutide) in people with type 2 diabetes mellitus and CKD at high-risk of progression (Table 1, Fig
It is not surprising that hepatic T3 signaling has a metabolic effect similar to those observed after nutrition ingestion on incretin GLP-1 through the regulation of CYP8B1 and non-12-OH FXR-antagonistic BAs
No serious adverse events were reported, and mild-to-moderate effects occurred similarly across groups
While having megaloblastic anemia, hyperhomocysteinemia, and/or neuropathy are not medical conditions that influence vitamin B12 absorption, they are clearly indications for the use of vitamin B12 supplements when deficiency is established
Twisting while lifting heavy objects places extreme stress on these muscles